LOS ANGELES -- (Business Wire)

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Foundation Medicine, Inc. (“Foundation” or the “Company”) (NASDAQ: FMI) investors concerning the Company and its officers’ possible violations of federal securities laws. To obtain information or aid in the investigation, please visit the Foundation page on our website at www.glancylaw.com/case/foundation-medicine-inc.

On July 29, 2015, the Company disclosed that “clinical volume growth was affected by slower than anticipated progress towards obtaining a local coverage determination from our regional Medicare Administrative Contractor (MAC) and by some competitive noise in the market” and that, as such, the Company was “adjusting” its guidance for clinical volume and annual revenues.

Then, on November 3, 2015, the Company disclosed a further revision to the already reduced number of clinical tests it expected to report for 2015. On this news, the price of Foundation common stock fell $6.62 per share, to close at $17.31 per share on November 4, 2015.

If you purchased Foundation securities, have information or would like to learn more about these claims, or have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley F. Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170919006053/en/

Contacts:

Glancy Prongay & Murray LLP, Los Angeles/New York
Lesley F. Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com

Source: Glancy Prongay & Murray LLP